Answers in CME at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Answers in CME is at ASH 2026 in New Orleans. Its presence centres on continuing education in blood cancers, and it runs a symposium on four-drug treatment for newly diagnosed multiple myeloma. It also covers turning evidence into action for patients with polycythemia vera and essential thrombocythemia.
| Organization | ASH 2026 Attendance |
|---|---|
Accredited medical education company producing continuing education programs for clinicians. | Symposium Fri Dec 11 3:00pm–6:00pm Quadruplet Therapy in NDMM: Interpreting the Data, Applying the Evidence Tailoring four-drug frontline regimens for newly diagnosed myeloma using residual disease testing, transplant criteria, and new ways of giving treatment. Symposium Fri Dec 11 7:00pm–10:00pm From Evidence to Action in MPN: Transforming Challenges to Opportunities in PV and ET Patients Treatment options for polycythemia vera and essential thrombocythemia after first-line therapy fails, including new targeted drugs for patients with unmet needs. |
Find decision makers at Answers in CME
Tell us what you sell and we’ll find the people at Answers in CME most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction